References
- Lavanchy, D. Evolving epidemiology of hepatitis C virus. Clin. Microbiol. Infect. 2011, 17, 107–115.
- Yoo, M.; Cheng, Y.; Rhien, T.J.; Biskupiak, J. Current issues in comparative effectiveness research for hepatitis C. Comp. Eff. Res. 2014, 4, 13–27.
- Yau, A.H.; Yoshida, E.M. Hepatitis C drugs: The end of the pegylated interferon era and the emergence of all-oral interferon-free antiviral regimens: A concise review. Can. J Gastroenterol. Hepatol. 2014, 28, 445–451.
- Cottarn, H.B.; Revankar, G.R.; Robins, R.K. A convenient Synthesis of 6-amino-1-β-D-ribofuranosylpyrazolo [3, 4-d] Pyrimidin-4-one and related 4, 6-disubstltuted pyrazodopyrimidine nucleosldes. Nucl. Acids Res. 1983, 11, 871–882.
- Thiyagarajan, A.; Salim, M.T.; Balaraju, T.; Bal, C.; Baba, M.; Sharon, A. Structure based medicinal chemistry approach to develop 4-methyl-7-deazaadenine carbocyclic nucleosides as anti-HCV agent. Bioorg. Med. Chem. Lett. 2012, 22, 7742–7747.
- Desiraju, G. R.; Steiner, T. The Weak Hydrogen Bond In Structural Chemistry and Biology. Oxford University Press Inc.: New York, 2001.
- Plevin, M.J.; Bryce, D.L.; Boisbouvier, J. Direct detection of CH/π interactions in proteins. Nat. Chem. 2010, 2, 466–471.
- Palusiak, M.; Grabowski, S.J. Methoxy group as an acceptor of proton in hydrogen bonds. J. Mol. Struct. 2002, 642, 97–104.
- Cho, J.H.; Bernard, D.L.; Sidwell, R.W.; Kern, E. R.; Chu, C.K. Synthesis of cyclopentenyl carbocyclic nucleosides as potential antiviral agents against orthopoxviruses and SARS. J. Med. Chem. 2006, 49, 1140–1148.
- Crystal data of 4a: C13H15N3O4, M = 277.28, orthorhombic, space group: P212121, a = 6.8816 (3), b = 7.7420 (3), c = 22.7848 (9) Å, a = 90.00, b = 90.00, g = 90.00, V = 1213.92 (8) Å3, T = 100 K, Z = 4, m = 0.96 mm−1, F(000) = 584.0, Dc = 1.517 Mg m−1, S = 1.064, colorless crystal, crystal size: 0.18 × 0.13 × 0.05 mm, 2639 reflections measured, 1794 unique, R1 = 0.0378 for 1619 Fo >4sig(Fo) and 0.0445 for all 1794 data and 186 parameters.
- Windisch, M. P.; Frese, M.; Kaul, A.; Trippler, M.; Lohmann, V.; Bartenschlager, R. Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line. J. Vir. 2005, 79, 13778–13793.
- Salim, M. T.; Aoyama, H.; Sugita, K.; Watashi, K.; Wakita, T.; Hamasaki, T.; Okamoto, M.; Urata, Y.; Hashimoto, Y.; Baba, M. Potent and selective inhibition of hepatitis C virus replication by novel phenanthridinone derivatives. Biochem. Bioph. Res. Commun. 2011, 415, 714–719.
- Goto, K.; Watashi, K.; Murata, T.; Hishiki, T.; Hijikata, M.; Shimotohno, K. Evaluation of the anti-hepatitis C virus effects of cyclophilin inhibitors, cyclosporin A, and NIM811. Biochem. Bioph. Res. Commun. 2006, 343, 879–84.